medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2022-27-85-87medalphabet-2878Research ArticleКЛИНИЧЕСКИЙ СЛУЧАЙCLINICAL CASEОпыт применения ацитретина при генитальной форме склероатрофического лихена с поражением уретры у мужчиныExperience of using acitretin in genital form of scleroatrophic lichen with urethral lesion in menИгнатовскийА. В.IgnatovskyA. V.

Игнатовский Андрей Викторович, к.м.н., доцент кафедры инфекционных болезней, эпидемиологии и дерматовенерологии

Санкт-Петербург 

Ignatovsky Andrei V., PhD Med, associate professor at Dept of Infectious Diseases, Epidemiology and Dermatovenereology 

Saint Petersburg 

 

derm@list.ruФГБОУ ВО «Санкт-Петербургский государственный университет»РоссияSaint Petersburg State UniversityRussian Federation202230112022127Дерматология (2)8587Copyright © Игнатовский А.В., 20222022Игнатовский А.В.Ignatovsky A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2878

Поражение половых органов при склероатрофическом лихене нередко сопровождается вовлечением в процесс уретры, что грозит серьезными осложнениями и в первую очередь развитием стриктуры. Терапия таких случает представляется затруднительной и малоэффективной в случае применения топических кортикостероидов. В статье описывается положительный опыт применения ацитретина в дозе 25 мг в сутки для лечения склероатрофического лихена, протекающего с поражением наружного отверстия и переднего отрезка уретры.

The defeat of the genitals in scleroatrophic lichen is often accompanied by the involvement of the urethra in the process, which threatens serious complications and, first of all, the development of stricture. Therapy of such cases is difficult and ineffective in the case of topical corticosteroids. The article describes the positive experience of using acitretin at a dose of 25 mg per day for the treatment of scleroatrophic lichen, which occurs with damage to the external orifice and anterior segment of the urethra.

склероатрофический лихенацитретинстриктура уретрыscleroatrophic lichenacitretinurethral strictureReferencesStewart L, McCammon K, Metro M, Virasoro R (2014). SIU/ICUD consultation on urethral strictures: Anterior urethra-lichen sclerosus. Urology 83 (3 Suppl): S27–30.Stewart L, McCammon K, Metro M, Virasoro R (2014). SIU/ICUD consultation on urethral strictures: Anterior urethra-lichen sclerosus. Urology 83 (3 Suppl): S27–30.Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int. 2000; 86: 459–465.Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int. 2000; 86: 459–465.Riddell L, Edwards A, Sherrard J. Clinical features of lichen sclerosus in men attending a department of genitourinary medicine. Sex Transm Infect. 2000; 76: 311–313 (Current treatment of lichen sclerosus and stricture Amanda S.J. Chung, Oscar A. Suarez).Riddell L, Edwards A, Sherrard J. Clinical features of lichen sclerosus in men attending a department of genitourinary medicine. Sex Transm Infect. 2000; 76: 311–313 (Current treatment of lichen sclerosus and stricture Amanda S.J. Chung, Oscar A. Suarez).Erickson BA, Elliott SP, Myers JB, Voelzke BB, Smith TG 3rd, McClung CD et al (2016). Understanding the relationship between chronic systemic disease and lichen sclerosus urethral strictures. J Urol 195 (2): 363–368.Erickson BA, Elliott SP, Myers JB, Voelzke BB, Smith TG 3rd, McClung CD et al (2016). Understanding the relationship between chronic systemic disease and lichen sclerosus urethral strictures. J Urol 195 (2): 363–368.Grimes MD, Tesdahl BA, Schubbe M, Dahmoush L, Pearlman AM, Kreder KJ et al (2019). Histopathology of anterior urethral strictures: towards a better understanding of stricture pathophysiology. J Urol. https://doi.org/10.1097/JU.0000000000000340.Grimes MD, Tesdahl BA, Schubbe M, Dahmoush L, Pearlman AM, Kreder KJ et al (2019). Histopathology of anterior urethral strictures: towards a better understanding of stricture pathophysiology. J Urol. https://doi.org/10.1097/JU.0000000000000340.Homer L., Buchanan, K.J., Nasr, B., Losty, P.D., & Corbett, H.J. (2014). Meatal stenosis in boys following circumcision for lichen sclerosus (balanitis xerotica obliterans). The journal of Urology, 192(6), 1784–1788.Homer L., Buchanan, K.J., Nasr, B., Losty, P.D., & Corbett, H.J. (2014). Meatal stenosis in boys following circumcision for lichen sclerosus (balanitis xerotica obliterans). The journal of Urology, 192(6), 1784–1788.Liu JS, Walker K, Stein D, Prabhu S, Hofer MD, Han J et al (2014). Lichen sclerosus and isolated bulbar urethral stricture disease. J Urol 192 (3): 775–779.Liu JS, Walker K, Stein D, Prabhu S, Hofer MD, Han J et al (2014). Lichen sclerosus and isolated bulbar urethral stricture disease. J Urol 192 (3): 775–779.Клинические рекомендации «Стриктура уретры» (утв. Министерством здравоохранения РФ 4 июня 2021 г.).Clinical guidelines ‘Stricture of the urethra’ (approved by the Ministry of Health of the Russian Federation on June 4, 2021).Bousema MT, Romppanen U, Geiger JM et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol 1994; 30 (Pt 1): 225–231.Bousema MT, Romppanen U, Geiger JM et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol 1994; 30 (Pt 1): 225–231.Niinimaki A, Kallioinen M, Oikarinen A. Etretinate reduces connective tissue degeneration in lichen sclerosus et atrophicus. Acta Derm Venereol 1989; 69: 439–442.Niinimaki A, Kallioinen M, Oikarinen A. Etretinate reduces connective tissue degeneration in lichen sclerosus et atrophicus. Acta Derm Venereol 1989; 69: 439–442.Ranum A., & Pearson D.R. (2021). Acitretin therapy for vulvar lichen sclerosus complicated by recurrent squamous cell carcinoma. JAAD Case Reports, 8, 53–55.Ranum A., & Pearson D.R. (2021). Acitretin therapy for vulvar lichen sclerosus complicated by recurrent squamous cell carcinoma. JAAD Case Reports, 8, 53–55.Ioannides D, Lazaridou E, Apalla Z et al. Acitretin for severe lichen sclerosus of male genitalia: a randomized, placebo-controlled study. J Urol 2010; 183: 1395–1399.Ioannides D, Lazaridou E, Apalla Z et al. Acitretin for severe lichen sclerosus of male genitalia: a randomized, placebo-controlled study. J Urol 2010; 183: 1395–1399.Kirtschig G., Cooper S., Aberer W., Günthert A., Becker K., Jasaitiene D., … & Wojnarowska F. (2017). Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. Journal of the European Academy of Dermatology and Venereology: JEADV, 31 (2), e81–e83.Kirtschig G., Cooper S., Aberer W., Günthert A., Becker K., Jasaitiene D., … & Wojnarowska F. (2017). Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. Journal of the European Academy of Dermatology and Venereology: JEADV, 31 (2), e81–e83.Potts BA, Belsante MJ, Peterson AC (2016) Intraurethral steroids are a safe an efective treatment for stricture disease in patients with biopsy proven lichen sclerosus. J Urol 195 (6): 1790–1796.Potts BA, Belsante MJ, Peterson AC (2016) Intraurethral steroids are a safe an efective treatment for stricture disease in patients with biopsy proven lichen sclerosus. J Urol 195 (6): 1790–1796.Bousema MT, Romppanen U, Geiger JM, et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol. 1994; 30 (2): 225–231.Bousema MT, Romppanen U, Geiger JM, et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol. 1994; 30 (2): 225–231.

The authors declare that there are no conflicts of interest present.